Medicare Program; Request for Nominations for Members for the Medicare Evidence Development & Coverage Advisory Committee, 71573-71574 [2011-29784]
Download as PDF
Federal Register / Vol. 76, No. 223 / Friday, November 18, 2011 / Notices
Standards and Quality, Coverage and
Analysis Group, S3–02–01, 7500
Security Boulevard, Baltimore, MD
21244 or contact Ms. Ellis by phone
(410) 786–0309) or via email at
Maria.Ellis@cms.hhs.gov.
SUPPLEMENTARY INFORMATION:
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Medicare & Medicaid
Services
[CMS–3254–N]
Medicare Program; Request for
Nominations for Members for the
Medicare Evidence Development &
Coverage Advisory Committee
Centers for Medicare &
Medicaid Services, HHS.
ACTION: Notice.
AGENCY:
This notice announces the
request for nominations for membership
on the Medicare Evidence Development
& Coverage Advisory Committee
(MEDCAC). Among other duties, the
MEDCAC provides advice and guidance
to the Secretary of the Department of
Health and Human Services (the
Secretary) and the Administrator of the
Centers for Medicare & Medicaid
Services (CMS) concerning the
adequacy of scientific evidence
available to CMS for ‘‘reasonable and
necessary’’ determinations under
Medicare.
We are requesting nominations for
both voting and nonvoting members to
serve on the MEDCAC. Nominees are
selected based upon their individual
qualifications and not as representatives
of professional associations or societies.
We wish to ensure adequate
representation of the interests of both
women and men, members of all ethnic
groups and physically challenged
individuals. Therefore we encourage
nominations of qualified candidates
who can represent these interests.
The MEDCAC reviews and evaluates
medical literature, technology
assessments, and hears public testimony
on the evidence available to address the
impact of medical items and services on
health outcomes of Medicare
beneficiaries.
SUMMARY:
Nominations will be considered
if postmarked by Monday, January 30,
2012 and mailed to the address
specified in the ADDRESSES section of
this notice.
ADDRESSES: You may mail nominations
for membership to the following
address: Centers for Medicare &
Medicaid Services, Office of Clinical
Standards and Quality, Attention: Maria
Ellis, 7500 Security Boulevard, Mail
Stop: South Building 3–02–01,
Baltimore, MD 21244.
FOR FURTHER INFORMATION CONTACT:
Maria Ellis, Executive Secretary for the
MEDCAC, Centers for Medicare &
Medicaid Services, Office of Clinical
mstockstill on DSK4VPTVN1PROD with NOTICES
DATES:
VerDate Mar<15>2010
17:44 Nov 17, 2011
Jkt 226001
I. Background
The Secretary signed the initial
charter for the Medicare Coverage
Advisory Committee (MCAC) on
November 24, 1998. A notice in the
Federal Register (63 FR 68780)
announcing establishment of the MCAC
was published on December 14, 1998.
The MCAC name was updated to more
accurately reflect the purpose of the
committee and on January 26, 2007, the
Secretary published a notice in the
Federal Register (72 FR 3853),
announcing that the Committee’s name
changed to the Medicare Evidence
Development & Coverage Advisory
Committee (MEDCAC). The charter for
the committee was renewed by the
Secretary on November 24, 2010. The
current charter is effective for 2 years.
The MEDCAC is governed by
provisions of the Federal Advisory
Committee Act, Pub. L. 92–463, as
amended (5 U.S.C. App. 2), which sets
forth standards for the formulation and
use of advisory committees, and is
authorized by section 222 of the Public
Health Service Act as amended (42
U.S.C. 217A).
The MEDCAC consists of a pool of
100 appointed members including: 94
voting members of whom 6 are
designated patient advocates, and 6
nonvoting representatives of industry
interests. Members generally are
recognized authorities in clinical
medicine including subspecialties,
administrative medicine, public health,
biological and physical sciences,
epidemiology and biostatistics, clinical
trial design, health care data
management and analysis, patient
advocacy, health care economics,
medical ethics, or other relevant
professions.
The MEDCAC works from an agenda
provided by the Designated Federal
Official. The MEDCAC reviews and
evaluates medical literature, technology
assessments, and hears public testimony
on the evidence available to address the
impact of medical items and services on
health outcomes of Medicare
beneficiaries. The MEDCAC may also
advise CMS as part of Medicare’s
‘‘coverage with evidence development’’
initiative.
II. Provisions of the Notice
As of June 2012, there will be 30
membership terms expiring. Of the 30
PO 00000
Frm 00064
Fmt 4703
Sfmt 4703
71573
memberships expiring, 1 is a nonvoting
industry representative, 4 are voting
patient advocates and the remaining 25
membership openings are for the
general MEDCAC voting membership.
Accordingly, we are requesting
nominations for both voting and
nonvoting members to serve on the
MEDCAC. Nominees are selected based
upon their individual qualifications and
not as representatives of professional
associations or societies. We wish to
ensure adequate representation of the
interests of both women and men,
members of all ethnic groups and
physically challenged individuals.
Therefore, we encourage nominations of
qualified candidates from these groups.
All nominations must be
accompanied by curricula vitae.
Nomination packages must be sent to
Maria Ellis at the address listed in the
ADDRESSES section of this notice.
Nominees for voting membership must
also have expertise and experience in
one or more of the following fields:
• Clinical medicine including
subspecialties
• Administrative medicine
• Public health
• Biological and physical sciences
• Epidemiology and biostatistics
• Clinical trial design
• Health care data management and
analysis
• Patient advocacy
• Health care economics
• Medical ethics
• Other relevant professions
We are looking for experts in a
number of fields. Our most critical
needs are for experts in hematology;
genomics; Bayesian statistics; clinical
epidemiology; clinical trial
methodology; knee, hip, and other joint
replacement surgery; ophthalmology;
psychopharmacology; rheumatology;
screening and diagnostic testing
analysis; and vascular surgery. We also
need experts in biostatistics in clinical
settings, cardiovascular epidemiology,
dementia, endocrinology, geriatrics,
gynecology, minority health,
observational research design, stroke
epidemiology, and women’s health.
The nomination letter must include a
statement that the nominee is willing to
serve as a member of the MEDCAC and
appears to have no conflict of interest
that would preclude membership. We
are requesting that all curricula vitae
include the following:
• Date of birth
• Place of birth
• Social Security number
• Title and current position
• Professional affiliation
• Home and business address
• Telephone and fax numbers
E:\FR\FM\18NON1.SGM
18NON1
71574
Federal Register / Vol. 76, No. 223 / Friday, November 18, 2011 / Notices
• Email address
• List of areas of expertise
In the nomination letter, we are
requesting that the nominee specify
whether they are applying for a voting
patient advocate position, for another
voting position, or as a nonvoting
industry representative. Potential
candidates will be asked to provide
detailed information concerning such
matters as financial holdings,
consultancies, and research grants or
contracts in order to permit evaluation
of possible sources of conflict of
interest.
Members are invited to serve for
overlapping 2-year terms. A member
may serve after the expiration of the
member’s term until a successor is
named. Any interested person may
nominate one or more qualified persons.
Self-nominations are also accepted.
The current Secretary’s Charter for the
MEDCAC is available on the CMS Web
site at: https://www.cms.hhs.gov/FACA/
Downloads/medcaccharter.pdf, or you
may obtain a copy of the charter by
submitting a request to the contact listed
in the FOR FURTHER INFORMATION
CONTACT section of this notice.
Authority: 5 U.S.C. App. 2, section
10(a)(1) and (a)(2).
(Catalog of Federal Domestic Assistance
Program No. 93.773, Medicare—Hospital
Insurance; and Program No. 93.774,
Medicare—Supplementary Medical
Insurance Program.)
Dated: October 18, 2011.
Patrick Conway,
CMS Chief Medical Officer and Director,
Office of Clinical Standards and Quality,
Centers for Medicare & Medicaid Services.
[FR Doc. 2011–29784 Filed 11–17–11; 8:45 am]
BILLING CODE 4120–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Administration for Children and
Families
Submission for OMB Review;
Comment Request
Title: Regional Partnership Grant
(RPG) Program Data Collection.
OMB No.: 0970–0353.
Description
On September 30, 2007, the
Administration for Children and
Families (ACF), Children’s Bureau
awarded multi-year grants to 53 regional
partnerships grantees (RPGs) to improve
the safety, permanency and well-being
of children affected by
methamphetamine or other substance
abuse who have been removed or are at
risk of removal from their home. The
Child and Family Services Improvement
Act of 2006, the authorizing legislation
for the RPG program, required that a set
of performance indicators be established
to periodically assess the grantees’
outcomes. The legislation mandated that
these performance indicators be
developed through a consultative
process involving ACF, the Substance
Abuse and Mental Health Services
Administration (SAMHSA), and
representatives of the State or Tribal
agencies who are members of the
regional partnerships. The legislation
also requires the Secretary of the
Department of Health and Human
services to submit annually to Congress
a report that includes the performance
indicators established under this grant
program.
The final set of RPG performance
indicators was approved by ACF and
disseminated to the funded grantees in
January 2008. It includes a total of 23
indicators across four outcome domains:
Child/youth (9 indicators), adult (7
indicators), family/relationship (5
indicators), and regional partnership/
service capacity (2 indicators). It also
includes a core set of child and adult
demographic elements that will provide
important context needed to properly
analyze, explain and understand the
outcomes. No other national data
collection measures these critical child,
adult, family, and RPG outcomes
specifically for these children and
families. The data also will have
significant implications for policy and
program development for child wellbeing programs nationwide.
The purpose of this request is to
obtain OMB approval for an extension
of the original three year request which
was approved on March 31, 2009. Fortythree of the original 53 grantees were
awarded for a five-year grant period,
thus necessitating an extension of the
original request in order to continue
data collection for the remainder of the
grant period. The first submission of
RPG grantee data to the RPG data
collection system occurred in December,
2008, and every six months thereafter.
Data collection will be conducted for
the fifth year of the grant period, ending
September 30, 2012, with data
submission by January 2013. Data
collection may be extended for one year
until January 2014 should grantees
request and be granted no-cost
extensions.
To minimize grantee data collection
and reporting burden, many of the data
elements are already being collected by
counties and States in order to report
Federally-mandated data to the
Adoption and Foster Care Analysis and
Reporting System (AFCARS), the
Treatment Episode Data Set (TEDS) and
the National Outcome Measures
(NOMs); in addition, all States
voluntarily submit data for the Federal
National Child Abuse and Neglect Data
System (NCANDS). Therefore, most
child welfare data elements included in
the RPG performance measures can be
found in a State’s automated case
management system, which is often a
Federally-funded Statewide Automated
Child Welfare Information System
(SACWIS). TEDS admission and
discharge data are collected by State
substance abuse agencies according to
their own information systems for
monitoring substance abuse treatment
admissions and transmitted monthly or
quarterly to the SAMHSA contractor. As
a result of prior Federal government
reporting requirements, States are
already collecting several data elements
needed by the RPGs. The RPGs lead
agency or their state or local partners are
able to download information from
these existing State child welfare and
substance abuse treatment data systems
to obtain data to monitor their RPG
program outcomes, thereby reducing the
amount of primary data collection
needed.
Respondents
mstockstill on DSK4VPTVN1PROD with NOTICES
ANNUAL BURDEN ESTIMATES
Private Sector ..................................................................................
State, Local, or Tribal Government .................................................
VerDate Mar<15>2010
17:44 Nov 17, 2011
Jkt 226001
Number of
responses per
respondent
Number of
respondents
Instrument
PO 00000
Frm 00065
Fmt 4703
17
26
Sfmt 4703
E:\FR\FM\18NON1.SGM
Average
burden hours per
response
2
2
175.5
175.5
18NON1
Total burden
hours
5,967
9,126
Agencies
[Federal Register Volume 76, Number 223 (Friday, November 18, 2011)]
[Notices]
[Pages 71573-71574]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2011-29784]
[[Page 71573]]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Medicare & Medicaid Services
[CMS-3254-N]
Medicare Program; Request for Nominations for Members for the
Medicare Evidence Development & Coverage Advisory Committee
AGENCY: Centers for Medicare & Medicaid Services, HHS.
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: This notice announces the request for nominations for
membership on the Medicare Evidence Development & Coverage Advisory
Committee (MEDCAC). Among other duties, the MEDCAC provides advice and
guidance to the Secretary of the Department of Health and Human
Services (the Secretary) and the Administrator of the Centers for
Medicare & Medicaid Services (CMS) concerning the adequacy of
scientific evidence available to CMS for ``reasonable and necessary''
determinations under Medicare.
We are requesting nominations for both voting and nonvoting members
to serve on the MEDCAC. Nominees are selected based upon their
individual qualifications and not as representatives of professional
associations or societies. We wish to ensure adequate representation of
the interests of both women and men, members of all ethnic groups and
physically challenged individuals. Therefore we encourage nominations
of qualified candidates who can represent these interests.
The MEDCAC reviews and evaluates medical literature, technology
assessments, and hears public testimony on the evidence available to
address the impact of medical items and services on health outcomes of
Medicare beneficiaries.
DATES: Nominations will be considered if postmarked by Monday, January
30, 2012 and mailed to the address specified in the ADDRESSES section
of this notice.
ADDRESSES: You may mail nominations for membership to the following
address: Centers for Medicare & Medicaid Services, Office of Clinical
Standards and Quality, Attention: Maria Ellis, 7500 Security Boulevard,
Mail Stop: South Building 3-02-01, Baltimore, MD 21244.
FOR FURTHER INFORMATION CONTACT: Maria Ellis, Executive Secretary for
the MEDCAC, Centers for Medicare & Medicaid Services, Office of
Clinical Standards and Quality, Coverage and Analysis Group, S3-02-01,
7500 Security Boulevard, Baltimore, MD 21244 or contact Ms. Ellis by
phone (410) 786-0309) or via email at Maria.Ellis@cms.hhs.gov.
SUPPLEMENTARY INFORMATION:
I. Background
The Secretary signed the initial charter for the Medicare Coverage
Advisory Committee (MCAC) on November 24, 1998. A notice in the Federal
Register (63 FR 68780) announcing establishment of the MCAC was
published on December 14, 1998. The MCAC name was updated to more
accurately reflect the purpose of the committee and on January 26,
2007, the Secretary published a notice in the Federal Register (72 FR
3853), announcing that the Committee's name changed to the Medicare
Evidence Development & Coverage Advisory Committee (MEDCAC). The
charter for the committee was renewed by the Secretary on November 24,
2010. The current charter is effective for 2 years.
The MEDCAC is governed by provisions of the Federal Advisory
Committee Act, Pub. L. 92-463, as amended (5 U.S.C. App. 2), which sets
forth standards for the formulation and use of advisory committees, and
is authorized by section 222 of the Public Health Service Act as
amended (42 U.S.C. 217A).
The MEDCAC consists of a pool of 100 appointed members including:
94 voting members of whom 6 are designated patient advocates, and 6
nonvoting representatives of industry interests. Members generally are
recognized authorities in clinical medicine including subspecialties,
administrative medicine, public health, biological and physical
sciences, epidemiology and biostatistics, clinical trial design, health
care data management and analysis, patient advocacy, health care
economics, medical ethics, or other relevant professions.
The MEDCAC works from an agenda provided by the Designated Federal
Official. The MEDCAC reviews and evaluates medical literature,
technology assessments, and hears public testimony on the evidence
available to address the impact of medical items and services on health
outcomes of Medicare beneficiaries. The MEDCAC may also advise CMS as
part of Medicare's ``coverage with evidence development'' initiative.
II. Provisions of the Notice
As of June 2012, there will be 30 membership terms expiring. Of the
30 memberships expiring, 1 is a nonvoting industry representative, 4
are voting patient advocates and the remaining 25 membership openings
are for the general MEDCAC voting membership.
Accordingly, we are requesting nominations for both voting and
nonvoting members to serve on the MEDCAC. Nominees are selected based
upon their individual qualifications and not as representatives of
professional associations or societies. We wish to ensure adequate
representation of the interests of both women and men, members of all
ethnic groups and physically challenged individuals. Therefore, we
encourage nominations of qualified candidates from these groups.
All nominations must be accompanied by curricula vitae. Nomination
packages must be sent to Maria Ellis at the address listed in the
ADDRESSES section of this notice. Nominees for voting membership must
also have expertise and experience in one or more of the following
fields:
Clinical medicine including subspecialties
Administrative medicine
Public health
Biological and physical sciences
Epidemiology and biostatistics
Clinical trial design
Health care data management and analysis
Patient advocacy
Health care economics
Medical ethics
Other relevant professions
We are looking for experts in a number of fields. Our most critical
needs are for experts in hematology; genomics; Bayesian statistics;
clinical epidemiology; clinical trial methodology; knee, hip, and other
joint replacement surgery; ophthalmology; psychopharmacology;
rheumatology; screening and diagnostic testing analysis; and vascular
surgery. We also need experts in biostatistics in clinical settings,
cardiovascular epidemiology, dementia, endocrinology, geriatrics,
gynecology, minority health, observational research design, stroke
epidemiology, and women's health.
The nomination letter must include a statement that the nominee is
willing to serve as a member of the MEDCAC and appears to have no
conflict of interest that would preclude membership. We are requesting
that all curricula vitae include the following:
Date of birth
Place of birth
Social Security number
Title and current position
Professional affiliation
Home and business address
Telephone and fax numbers
[[Page 71574]]
Email address
List of areas of expertise
In the nomination letter, we are requesting that the nominee
specify whether they are applying for a voting patient advocate
position, for another voting position, or as a nonvoting industry
representative. Potential candidates will be asked to provide detailed
information concerning such matters as financial holdings,
consultancies, and research grants or contracts in order to permit
evaluation of possible sources of conflict of interest.
Members are invited to serve for overlapping 2-year terms. A member
may serve after the expiration of the member's term until a successor
is named. Any interested person may nominate one or more qualified
persons. Self-nominations are also accepted.
The current Secretary's Charter for the MEDCAC is available on the
CMS Web site at: https://www.cms.hhs.gov/FACA/Downloads/medcaccharter.pdf, or you may obtain a copy of the charter by
submitting a request to the contact listed in the FOR FURTHER
INFORMATION CONTACT section of this notice.
Authority: 5 U.S.C. App. 2, section 10(a)(1) and (a)(2).
(Catalog of Federal Domestic Assistance Program No. 93.773,
Medicare--Hospital Insurance; and Program No. 93.774, Medicare--
Supplementary Medical Insurance Program.)
Dated: October 18, 2011.
Patrick Conway,
CMS Chief Medical Officer and Director, Office of Clinical Standards
and Quality, Centers for Medicare & Medicaid Services.
[FR Doc. 2011-29784 Filed 11-17-11; 8:45 am]
BILLING CODE 4120-01-P